Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Electric bike-sharing firm Pony says all of its vehicles will be back out on the streets of Nice no later than June, after they were withdrawn last mo...
Read More
Gabriel Attal announced new measures In response to recent acts of violence among young people during a visit to Viry-Châtillon. Attal highlighted the...
Read More
The owners of a vast floating artificial island that had been planned for last summer off the coast of Mandelieu have won a legal battle to be allowed...
Read More
The Monegasque State has successfully conducted its first national voluntary surrender operation, with 123 firearms being handed over by private indiv...
Read More
A hospital in Cannes has had to postpone all non-urgent consultations and operations after falling victim to a cyberattack....
Read More
